You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, July 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Induction of Interferon by Nonviral Agents

Erik De Clercq, MD; Thomas C. Merigan, MD

Arch Intern Med. 1970;126(1):94-108.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Until 1963, only viruses were known to stimulate interferon production in cells. The nucleic acid of the virus was generally regarded as the essential stimulus for interferon production.1 Rotem et al and Isaacs et al2,3 demonstrated in 1963 that nonviral nucleic acids, provided they were foreign to the cells (heterologous or chemically modified homologous RNA), could also initiate the production of interferon. Although their "foreign nucleic acid" hypothesis was received with some scepticism and retracted later,4 it offered a reasonable explanation for the nucleic acid-induced resistance to viral infection, which had been described5 as early as 1953. Moreover, it raised a possible explanation for the antiviral action of agents such as bacteria or apparently nonviral agents as the mold products statolon (culture filtrate of Penicillium stoloniferum) and helenine (mycelium extract of Penicillium funiculosum) which had been found active in a number of experimental viral infections.6-13 . . . [Full Text PDF of this Article]


Author Affiliations

Stanford, Calif

From the Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, Calif. Dr. De Clercq is a Lilly International Fellow and "Aangesteld Navorser" of the Belgian Nationaal Fonds voor Wetenschappelijk Ondersoek.


Footnotes

Received for publication Nov 5, 1969; accepted, Jan 28, 1970.

Reprint requests to 300 Pasteur Dr, Stanford, Calif 94305 (Dr. Merigan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.